Insider Trading April 20, 2026 05:10 PM

OneMain Holdings EVP Sells $300,000 in OMF Stock as Company Navigates Earnings Beat and Legal Headwinds

Micah R. Conrad liquidated 5,000 shares under a pre-set trading plan; analysts trim targets amid a multi-state lawsuit despite a quarterly performance beat

By Caleb Monroe OMF
OneMain Holdings EVP Sells $300,000 in OMF Stock as Company Navigates Earnings Beat and Legal Headwinds
OMF

Micah R. Conrad, Executive Vice President and Chief Operating Officer at OneMain Holdings, Inc. (NYSE: OMF), sold common stock worth $300,000 on April 17, 2026. The transaction, executed under a Rule 10b5-1 trading plan established on November 18, 2025, consisted of 5,000 shares at $60.00 per share. The company recently reported fourth-quarter 2025 adjusted earnings that outperformed analyst expectations, driven by revenue growth and higher portfolio yield, but faces a multi-state lawsuit led by the New York Attorney General that prompted several analyst price-target cuts.

Key Points

  • Micah R. Conrad sold 5,000 OneMain shares at $60.00 per share on April 17, 2026 under a Rule 10b5-1 plan.
  • OneMain’s Q4 2025 adjusted earnings beat expectations due to revenue growth and improved portfolio yield.
  • Analysts trimmed price targets amid mixed guidance and a multi-state lawsuit led by the New York Attorney General.

Insider transaction

Micah R. Conrad, who serves as Executive Vice President and Chief Operating Officer at OneMain Holdings, Inc. (NYSE: OMF), disposed of common stock valued at $300,000 on April 17, 2026. The sale comprised 5,000 shares of the company’s common stock at a price of $60.00 per share. That execution price was slightly above the company’s then-current trading price of $59.92.

The trade was completed under a Rule 10b5-1 trading plan that Mr. Conrad established on November 18, 2025. Following the transaction, Mr. Conrad directly holds 101,250 shares of OneMain common stock.

Share performance and valuation metrics

Over the past 12 months, OneMain’s stock has delivered approximately a 44% return. At present the company trades at a price-to-earnings ratio of 9.12 and offers a dividend yield of 7.09%.

InvestingPro subscribers have access to 10 additional ProTips for OMF, plus comprehensive Pro Research Reports covering 1,400+ US stocks with expert analysis and actionable intelligence.

Recent financial results and analyst reactions

OneMain reported fourth-quarter 2025 adjusted earnings that beat analyst expectations, a result the company attributed to robust revenue growth and an improved portfolio yield. Those results were noted alongside company commentary on execution in a challenging economic backdrop.

Following the quarterly update and accompanying guidance, several analysts adjusted their price targets while maintaining their ratings. BofA Securities reduced its price target for OneMain to $74 from $75 and kept a Buy rating, citing mixed guidance from the company. Wells Fargo lowered its target to $70 from $75 and maintained an Equal Weight rating, noting the company’s cautious underwriting stance amid ongoing inflation and economic uncertainty.

In a separate note, Evercore ISI cut its price target to $55 from $69 and maintained an In Line rating after a multi-state lawsuit was filed against OneMain. The lawsuit, led by the New York Attorney General, alleges that the company engaged in deceptive practices by including optional insurance and add-on products in loans, potentially misleading customers about the total cost.

Analyst sentiment and the broader picture

These developments have generated a mix of analyst sentiment toward OneMain as market participants weigh the company’s strong reported financial performance alongside legal and regulatory challenges. The adjustments in price targets reflect differing assessments of how the reported earnings, guidance, and the pending lawsuit should influence near-term valuation.


Summary

Micah R. Conrad sold 5,000 OneMain shares for $60.00 apiece on April 17, 2026, under a Rule 10b5-1 plan established November 18, 2025, reducing his direct holdings to 101,250 shares. OneMain posted better-than-expected adjusted earnings for Q4 2025 driven by revenue growth and higher portfolio yield; analysts have responded with mixed target adjustments amid a multi-state lawsuit led by the New York Attorney General.

Key points

  • Insider sale: Conrad sold 5,000 shares at $60.00, totaling $300,000, under a Rule 10b5-1 plan set on November 18, 2025 - this impacts investor attention to insider activity in the credit and consumer finance sectors.
  • Quarterly results: OneMain’s fourth-quarter 2025 adjusted earnings exceeded expectations, driven by revenue growth and improved portfolio yield - a relevant datapoint for lenders and credit-focused financials.
  • Analyst adjustments: Price targets were trimmed by multiple firms - BofA to $74 (from $75, Buy), Wells Fargo to $70 (from $75, Equal Weight), and Evercore ISI to $55 (from $69, In Line) - reflecting mixed market views amid operational and legal developments.

Risks and uncertainties

  • Regulatory and legal risk: A multi-state lawsuit led by the New York Attorney General alleges deceptive practices related to optional insurance and add-on products in loans - this directly affects OneMain and bears on the consumer credit sector.
  • Guidance and underwriting caution: Company guidance described as mixed, and a cautious approach to underwriting amid inflation and economic uncertainty was noted by analysts - this creates near-term execution risk in credit origination and asset quality.

Note: The article presents facts on the insider transaction, recent results, analyst actions, and legal developments without extrapolating beyond the information provided.

Risks

  • Multi-state lawsuit led by the New York Attorney General alleging deceptive practices related to optional insurance and add-on products in loans - impacts consumer credit sector.
  • Company’s mixed guidance and cautious underwriting in the face of inflation and economic uncertainty - impacts lending and credit quality.

More from Insider Trading

Bicara Therapeutics CEO Disposes $354,145 in Shares, Exercises Options Amid Stock Rally Apr 20, 2026 Broadwood Partners Completes $652,875 Open-Market Purchases in Insight Molecular Diagnostics Apr 20, 2026 Arista Networks CEO Sells $55.76 Million in Stock via Family Trusts Apr 20, 2026 WEX COO Executes $612,500 Stock Sale; Company Nears 52-Week High Ahead of Earnings Apr 20, 2026 AMREP insiders increase holdings as shares trade near 52-week high Apr 20, 2026